Menu
GeneBe

SETD7

SET domain containing 7, histone lysine methyltransferase, the group of SET domain containing|Lysine methyltransferases

Basic information

Region (hg38): 4:139495940-139606699

Links

ENSG00000145391NCBI:80854OMIM:606594HGNC:30412Uniprot:Q8WTS6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SETD7 gene.

  • Inborn genetic diseases (5 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SETD7 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
5
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 5 0 1

Variants in SETD7

This is a list of pathogenic ClinVar variants found in the SETD7 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-139517889-C-T not specified Uncertain significance (Jun 28, 2022)2354425
4-139517893-G-C not specified Uncertain significance (Nov 08, 2022)2362567
4-139517897-C-G not specified Uncertain significance (Dec 09, 2023)3160694
4-139517942-C-G not specified Uncertain significance (Sep 07, 2022)2407880
4-139523369-G-A not specified Uncertain significance (Jan 03, 2022)2216418
4-139533194-G-A not specified Uncertain significance (May 16, 2022)2289728
4-139533320-C-T not specified Uncertain significance (Dec 08, 2023)3160692
4-139547024-C-T Benign (Dec 31, 2019)786048

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SETD7protein_codingprotein_codingENST00000274031 8110759
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.004230.9891257180291257470.000115
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.661432110.6790.00001122403
Missense in Polyphen4676.3620.60239812
Synonymous-0.2298582.41.030.00000506687
Loss of Function2.38717.80.3938.12e-7229

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00003220.0000322
Ashkenazi Jewish0.001690.00169
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00009730.0000967
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Histone methyltransferase that specifically monomethylates 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Plays a central role in the transcriptional activation of genes such as collagenase or insulin. Recruited by IPF1/PDX-1 to the insulin promoter, leading to activate transcription. Has also methyltransferase activity toward non-histone proteins such as p53/TP53, TAF10, and possibly TAF7 by recognizing and binding the [KR]-[STA]-K in substrate proteins. Monomethylates 'Lys-189' of TAF10, leading to increase the affinity of TAF10 for RNA polymerase II. Monomethylates 'Lys-372' of p53/TP53, stabilizing p53/TP53 and increasing p53/TP53-mediated transcriptional activation. {ECO:0000269|PubMed:12540855, ECO:0000269|PubMed:12588998, ECO:0000269|PubMed:15099517, ECO:0000269|PubMed:15525938, ECO:0000269|PubMed:16141209, ECO:0000269|PubMed:17108971}.;
Pathway
Lysine degradation - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);Carnitine Synthesis;Histone Modifications;PKMTs methylate histone lysines;Chromatin modifying enzymes;Lysine metabolism;Chromatin organization;p53 pathway (Consensus)

Recessive Scores

pRec
0.156

Intolerance Scores

loftool
0.273
rvis_EVS
0.08
rvis_percentile_EVS
60.31

Haploinsufficiency Scores

pHI
0.578
hipred
Y
hipred_score
0.831
ghis
0.498

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.987

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Setd7
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype;

Zebrafish Information Network

Gene name
setd7
Affected structure
heart
Phenotype tag
abnormal
Phenotype quality
linear

Gene ontology

Biological process
chromatin organization;cellular response to DNA damage stimulus;peptidyl-lysine monomethylation;peptidyl-lysine dimethylation;histone lysine methylation;response to ethanol;positive regulation of transcription, DNA-templated;regulation of histone H3-K9 methylation;heterochromatin organization
Cellular component
nucleoplasm;chromosome;nucleolus
Molecular function
p53 binding;chromatin binding;protein binding;protein-lysine N-methyltransferase activity;histone-lysine N-methyltransferase activity